Biodesix, Inc. Common Stock earnings per share and revenue
On Jan 12, 2026, BDSX reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.87 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 26.24 million, with a --% difference. The market reacted with a +47.99% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 5 analysts forecast an EPS of -1.07 USD, with revenue projected to reach 24.18 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Biodesix, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Biodesix, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Biodesix, Inc. Common Stock's Q4 2025 earnings?
The stock price moved up 47.99%, changed from $5.46 before the earnings release to $8.08 the day after.
When is Biodesix, Inc. Common Stock expected to report next?
The next earning report is scheduled for May 11, 2026.
What are the forecasts for Biodesix, Inc. Common Stock's next earnings report?
Based on 5
analysts, Biodesix, Inc. Common Stock is expected to report EPS of -$1.07 and revenue of $24.18M for Q1 2026.